Hutson P A, Holgate S T, Church M K
Immunopharmacology Group, Southampton General Hospital, United Kingdom.
Am Rev Respir Dis. 1988 Nov;138(5):1157-63. doi: 10.1164/ajrccm/138.5.1157.
We describe the effects of the antiallergic drug cromolyn sodium and the beta 2-selective adrenoceptor agonist albuterol against early and late phase changes in specific airways conductance (sGaw) and leukocyte infiltration into the airways after allergen challenge of nonanesthetized guinea pigs. Inhalation of ovalbumin by sensitized guinea pigs induced three phases of airways obstruction: an early asthmatic response (EAR) peaking at 2 h, a late response (LAR) peaking at 17 h, and a further late response (LLAR) being observed at 72 h. The LAR was accompanied by a 13-fold rise in neutrophils and a four-fold rise in eosinophils recovered by bronchoalveolar lavage (BAL) at 17 h. By 72 h, the BAL content of neutrophils had returned to near normal, whereas eosinophil numbers had risen to 6.7-fold above baseline. Inhalation of an aerosolized solution of cromolyn, 10 mg/ml, 15 min before challenge inhibited both the EAR and LAR and the influx of neutrophils into the airways at 17 h but had no effect on eosinophil accumulation. Inhalation of cromolyn at 6 h, i.e., after the completion of the EAR, inhibited the LAR, the LLAR, and the rise in eosinophils at 72 h but did not reduce the influx of neutrophils at 17 h. Administration of cromolyn at both 15 min before and 6 h after challenge inhibited all changes in sGaw and reduced the accumulation of neutrophils at 17 h and the influx of eosinophils at 72 h. In contrast, inhalation of albuterol, 0.1 mg/ml, 15 min before allergen provocation blocked the EAR and the rise in BAL neutrophils at 17 h but did not inhibit the LAR. Inhalation of albuterol at 6 h partially reversed the LAR but had no effect on either the LLAR or cellular changes. Given at both times, albuterol inhibited the EAR and neutrophil accumulation at 17 h and partially reversed the LAR but produced no other effects.(ABSTRACT TRUNCATED AT 250 WORDS)
我们描述了抗过敏药物色甘酸钠和β2选择性肾上腺素能受体激动剂沙丁胺醇对未麻醉豚鼠过敏原激发后气道比传导率(sGaw)的早期和晚期变化以及白细胞浸润气道的影响。致敏豚鼠吸入卵清蛋白会引发三个阶段的气道阻塞:在2小时达到峰值的早期哮喘反应(EAR)、在17小时达到峰值的晚期反应(LAR)以及在72小时观察到的进一步晚期反应(LLAR)。LAR伴随着支气管肺泡灌洗(BAL)在17小时回收的中性粒细胞增加13倍和嗜酸性粒细胞增加4倍。到72小时,BAL中的中性粒细胞含量已恢复到接近正常水平,而嗜酸性粒细胞数量则升至基线以上6.7倍。在激发前15分钟吸入10mg/ml的色甘酸雾化溶液可抑制EAR和LAR以及17小时时中性粒细胞流入气道,但对嗜酸性粒细胞聚集无影响。在EAR结束后的6小时吸入色甘酸,即抑制LAR、LLAR以及72小时时嗜酸性粒细胞的增加,但不会减少17小时时中性粒细胞的流入。在激发前15分钟和激发后6小时都给予色甘酸可抑制sGaw的所有变化,并减少17小时时中性粒细胞的聚集以及72小时时嗜酸性粒细胞的流入。相比之下,在过敏原激发前15分钟吸入0.1mg/ml的沙丁胺醇可阻断EAR和17小时时BAL中性粒细胞的增加,但不抑制LAR。在6小时吸入沙丁胺醇可部分逆转LAR,但对LLAR或细胞变化均无影响。在两个时间点都给予沙丁胺醇可抑制EAR和17小时时中性粒细胞的聚集,并部分逆转LAR,但无其他作用。(摘要截选至250字)